Net Asset Value(s)
Summary by AI BETAClose X
Templeton Emerging Markets Investment Trust reported unaudited cum-income NAV as at 02 November 2026 of £2,924.366m (324.84p per share) and unaudited ex-income NAV of £2,884.730m (320.43p per share), implying an accrued income component of £39.636m (4.41p per share), roughly 1.38% of the ex-income NAV; NAVs were calculated using bid prices on underlying assets.
Templeton Emerging Markets IT PLC
03 November 2026
Templeton Emerging Markets Investment Trust PLC ('TEMIT')
On behalf of TEMIT, Franklin Templeton Investment Trust Management Limited reports the unaudited cum-income net asset value ('NAV') of TEMIT as at
02 November 2026 was £2924.366m, representing a NAV of 324.84 pence per share.
The unaudited ex-income NAV of TEMIT as at 02 November 2026 was £2884.730m, representing a NAV of 320.43 pence per share.
In accordance with the Association of Investment Companies recommendations, the cum-income NAV has been calculated based on the total value of underlying assets,
including accumulated or accrued income, and using bid price information relating to the underlying assets.
The ex-income NAV has been calculated based on the total value of underlying assets, excluding these income elements, and using bid price information relating to the underlying assets.
Portfolio data for TEMIT can be found on the website www.TEMIT.co.uk.
For information please contact Client Dealer Services on freephone 0800 305 306.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 3 hours ago Johnson Matthey
- 5 hours ago Galliford Try
- 5 hours ago Galliford Try
- 5 hours ago Centrica
- 6 hours ago Smith & Nephew